CD8A and neoplasm: It has been shown that anti-angiogenic treatments could induce the normalisation of the tumor vasculature [83], which enhances anti-tumor immunity by increasing antigen presentation in dendritic cells, the populations of M1-like macrophages and active CD8+ T-cells [84].